Companies: 10,795·Total market cap: $144.5T
Rennova Health, Inc.

Rennova Health, Inc.

RNVAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4305132
P/E Ratio
52W High$0.0001
52W Low$0.0001

Rennova Health, Inc. (RNVA) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

RNVA · cash on hand · updated Dec 31, 2023

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$49,015 -90.2% vs prior year
FY · as of Dec 31, 2023 · Reported in USD
Cash & Cash Equiv. (CCE)
$49,015
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-90.2%
vs prior fiscal year
Latest Quarter
$49,015
Q4 2023
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2023

Net cash vs debt

Cash & ST Investments$49,015Cash on Hand
Total Debt$11.8MTotal Debt
Net Cash / Net Debt−$11.7MNet Debt Position
Cash vs Debt Ratio
Cash 0%Debt 100%

Rennova Health, Inc. carries a net debt position of $11.7M. Total debt ($11.8M) exceeds cash on hand ($49,015). Rennova Health, Inc. cash vs debt ratio: 0% cash / 100% debt.

Net Cash = Cash & ST Investments − Total Debt$49,015$11.8M = −$11.7M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
RNVA annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2023Latest$0.0M-90.2%
Dec 31, 2022$0.5M-31.1%
Dec 31, 2021$0.7M+2757.7%
Dec 31, 2020$0.0M+49.7%
Dec 31, 2019$0.0M+146.5%
RNVA cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Rennova Health, Inc.
Rennova Health, Inc.YOU
RNVA
$0.0M1.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Rennova Health, Inc. (RNVA) cash on hand as of December 31, 2023 is $49,015, comprising $49,015 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Rennova Health, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Rennova Health, Inc. cash reserves or cash position.

Rennova Health, Inc. annual cash on hand history shows decreased -90.2% in 2023: decreased -90.2% in 2023. Rennova Health, Inc. cash reserves in 2023 reflect the company's capital allocation strategy.

Rennova Health, Inc. carries total debt of $11.8M against cash of $49,015, resulting in a net debt position of -$11.7M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

RNVA cash on hand · 5 questions

As of December 31, 2023, Rennova Health, Inc. (RNVA) has $49,015 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $49,015 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2023): $49,015. Data sourced from the annual 10-K filing via FMP.

RNVA cash on handRNVA cash reservesRNVA cash 2023how much cash does RNVA have

Source: FMP /balance-sheet-statement · US GAAP · Rennova Health, Inc. · Rennova Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2023